MVM Partners has closed its sixth healthcare fund, MVM VI, with $500m in limited partner commitments. Demand was well above the hard cap. MVM has been investing in high growth healthcare businesses since 1997.
MVM VI will continue this broad, global remit with investments in medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, pharma services and digital health.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
MVM invests in both private and public companies. Typical projected investment in each company is $30 to $60 million, but with capacity for larger investments.
MVM has been investing in high growth healthcare businesses since 1997. MVM VI will continue this broad, global remit with investments in medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, pharma services and digital health. MVM invests in both private and public companies.
Source: Private Equity Wire
Can’t stop reading? Read more
CapVest-backed IPN acquires premium pet food producer Sopral from Parquest
CapVest-backed IPN acquires premium pet food producer Sopral from Parquest CapVest Partners has...
Coller Capital secures record $6.8bn for private credit secondaries fund
Coller Capital secures record $6.8bn for private credit secondaries fund Coller Capital has closed...
Ardian exits landmark Paris asset following successful repositioning strategy
Ardian exits landmark Paris asset following successful repositioning strategy Ardian has completed...